← Back to Golden Gate Capital profile
Golden Gate Capital related stories
All articles and analysis
Deal round-upMowbray launches European venture FoF; Apatech raises £6.5 million in Series B financing; KKR leads $250m pharma round; ARCH Venture closes $350m Fund VI;
- North Castle, Golden Gate in $650m recap
The recapitalisation of vitamin maker Leiner Health Products includes the sale of North Castle's majority stake, yielding the firm about three times capital invested.
- KKR leads $250m pharma round
Jazz Pharmaceuticals snags one of the largest second round financings on record for a speciality pharma company without any commercialized drugs.
- Yale Endowment under union pressure
Yale University has come under attack from trade unions in the US alleging non-disclosure of some of its investments and conflicts of interest involving members of the Investment Committee.